In vitro metabolism study of ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA using human hepatocytes, liver microsomes, and in‐house synthesized references
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3773 ↗At a glance
Journal article in Drug Testing and Analysis, 2025. Written by Tobias Rautio and 6 co-authors. Institution: Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden. Major MEDLINE topics: Hepatocytes, Microsomes, Liver, Cannabinoids, Indazoles. Cited 4 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY 4.0). Funded by: Strategic Research Area in Forensic Sciences, Linköping University, Linköpings Universitet.
Abstract (original language)
Synthetic cannabinoids (SCs) remain a major public health concern, as they continuously are linked to severe intoxications and drug‐related deaths worldwide. As new SCs continue to emerge on the illicit drug market, an understanding of SC metabolism is needed to identify formed metabolites that may serve as biomarkers in forensic toxicology screening and for understanding the pharmacokinetics of the drugs. In this work, the metabolism of ADB‐4en‐P‐5Br‐INACA and ADB‐P‐5Br‐INACA (( S )‐ N ‐(1‐amino‐3,3‐dimethyl‐1‐oxobutan‐2‐yl)‐5‐bromo‐1‐(pent‐4‐en‐1‐yl)‐1 H ‐indazole‐3‐carboxamide, ( S )‐ N ‐(1‐amino‐3,3‐dimethyl‐1‐oxobutan‐2‐yl)‐5‐bromo‐1‐pentyl‐1 H ‐indazole‐3‐carboxamide respectively) were investigated using human hepatocytes in vitro and in‐house synthesized references. Both SCs were incubated with pooled human hepatocytes over 3 h, with the aim to identify unique and abundant metabolites using liquid chromatography–quadrupole time‐of‐flight mass spectrometry (LC‐QTOF‐MS). In total nine metabolites were identified for ADB‐4en‐P‐5Br‐INACA and 10 metabolites for ADB‐P‐5Br‐INACA. The observed biotransformations included dihydrodiol formation, terminal amide hydrolysis, hydroxylation, dehydrogenation, carbonyl formation, glucuronidation, and combinations thereof. The major metabolites were confirmed by in‐house synthesized references. Recommended biomarkers for ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA are the terminal hydroxy and dihydrodiol metabolite respectively.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.
- University of Applied Sciences Northwestern, Windisch, Switzerland.
- Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden.
- Division of Drug Research, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
ORCID profiles: Tobias Rautio, Henrik Gréen
Funding
- Strategic Research Area in Forensic Sciences
- Linköping University
- Linköpings Universitet
Cite
APA
Rautio, T., Obrist, R., Krebs, L., Klingstedt, T., Dahlén, J., Wu, X., & Gréen, H. (2025). In vitro metabolism study of ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA using human hepatocytes, liver microsomes, and in‐house synthesized references. Drug Testing and Analysis. https://doi.org/10.1002/dta.3773
Vancouver
Rautio T, Obrist R, Krebs L, Klingstedt T, Dahlén J, Wu X, et al. In vitro metabolism study of ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA using human hepatocytes, liver microsomes, and in‐house synthesized references. Drug Testing and Analysis. 2025. doi:10.1002/dta.3773
BibTeX
@article{Rautio2025,
author = {Rautio, Tobias and Obrist, Robin and Krebs, Lucas and Klingstedt, Therése and Dahlén, Johan and Wu, Xiongyu and Gréen, Henrik},
title = {In vitro metabolism study of ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA using human hepatocytes, liver microsomes, and in‐house synthesized references},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3773}
}
EUVIMED